Michael Mano is SVP, General Counsel&Secretary of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 273,881 shares of KPTI, which is worth approximately $208,149. The most recent transaction as insider was on Sep 04, 2024, when has been sold 3,971 shares (Common Stock) at a price of $0.72 per share, resulting in proceeds of $2,859. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 274K
1.43% 3M change
92.56% 12M change
Total Value Held $208,149

Michael Mano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 04 2024
SELL
Open market or private sale
$2,859 $0.72 p/Share
3,971 Reduced 1.43%
273,881 Common Stock
Mar 01 2024
SELL
Open market or private sale
$4,291 $1.2 p/Share
3,576 Reduced 1.27%
277,852 Common
Feb 29 2024
SELL
Open market or private sale
$19,858 $1.17 p/Share
16,973 Reduced 5.69%
281,428 Common
Feb 28 2024
BUY
Grant, award, or other acquisition
-
147,000 Added 33.0%
298,401 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
9,167 Added 5.71%
151,401 Common Stock
Sep 01 2023
SELL
Open market or private sale
$5,171 $1.33 p/Share
3,888 Reduced 2.66%
142,234 Common Stock
Mar 01 2023
SELL
Open market or private sale
$20,840 $3.03 p/Share
6,878 Reduced 4.5%
146,122 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
-
70,000 Added 31.39%
153,000 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
20,000 Added 19.42%
83,000 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
63,000 Added 50.0%
63,000 Common Stock
MM

Michael Mano

SVP, General Counsel&Secretary
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI